MYC targets, unfolded protein response, and epithelial-mesenchymal transition (EMT) were upregulated, whereas the late response to estrogen, bile acid metabolism, and the KRAS signaling DN pathway was downregulated in the patients in the COAD group (Figure 3C). The gene discussed is KRAS; the disease is colon adenocarcinoma.